Functional Dyspepsia Clinical Trial
Official title:
Evaluation of the Efficacy of the Integral Approach (Therapeutic Encounter) Versus the Conventional Medical Approach (Medical Consultation) in Patients With Functional Dyspepsia
This study aims to evaluate, in patients with functional dyspepsia, a model example of medical care based upon the biopsychosocial model (called: the therapeutic encounter) compared with standard medical care based upon the biomedical model (called: medical consultation).
INTRODUCTION Addressing the high costs involved in new medical technology (biotechnology) is
a problem that has led individuals and public health services to feel increasingly
powerless.
Many authors say that not even an efficient use of resources can ensure better care and
health care, a true bottomless pit.
The problem is the conceptual and ideological bases of thinking and acting of the
professionals involved. The first misunderstanding is the "narrow approach" and the second
is the "process of medicalization."
The curative model and the restricted approach The curative model gets this name because it
is not concerned with the causes of the disease process (prevention), only with the effects
(the disease). As the effects can be mitigated or even extinct, it is only temporary,
because sooner or later they will return with the same format or not, in the same individual
or another. It is extremely costly for individuals and for society, because the solutions
are palliative. The approach is limited and so are results too.
The process of medicalization Medicalization is the ultimate expression of the distortions
of thinking and consequences of the model of health care regulations. It can be understood
as the increasingly high dependence on individuals and society overestimating the role that
biotechnology could play, and creating a dependency in which one believes that for any
problem, regardless of its severity or causal links, there will be a life-saving treatment.
The wrong postures and maintenance of unhealthy habits The model of health care can lead to
wrong postures. Many of today's health problems have a direct causal relationship with the
passive attitude of individuals, who delegate (to health care and biotechnology) full
responsibility for treating their ailments, are reluctant to bring about changes in habits
and behaviors because the "curative medicine holds that the doctors can take a magic bullet
and get our problems solved."
The strong interest in maintaining the healing model The curative model has a tendency to
concentrate on the application of biotechnology to strengthen the multinational
pharmaceutical industry and large firms in highly sophisticated biomedical equipment. This
has generated a stunning increase of expenditure on health as well as strong interest in
this market maintaining its hegemonic space through emphasis on "cure(medicalization of
life", rather than the emphasis on prevention and changing habits.
Aim of the study This study will aim to test, in patients with functional dyspepsia, a model
example of medical care based upon the biopsychosocial model (called: the therapeutic
encounter) compared with standard medical care based upon the biomedical model (called:
medical consultation).
What is the biopsychosocial model The biopsychosocial model does not focus exclusively on
organic disease. It considers the thinking process of becoming ill with multiple
causalities. It tries to understand the man, their psychological, biological, socio-cultural
and spiritual interconnections. It argues that the way of being and becoming ill are
constructions of the life history of each individual, where the psychological and
physiological are inextricably linked. In this perspective, disease becomes an expression of
internal conflicts, has a personal character and is linked to the person's relationship with
his world (its environment).
This approach has important consequences in medical practice as the doctor's focus of
attention shifts to the individual diseases.
The medical care based upon the biopsychosocial model conserves the characteristics of art
of medicine. Art in the sense of craftsmanship (the "tailored") as opposed to biomedical
technique that is (to systematize, generalize). In fact one must know deeply the technique
to apply it with art.
The primary focus continues to be what the patient has in common with others, but in its
quirks (it is the art of medicine). It is considered less important if a particular
treatment will work, thinking of the majority of patients (the technique), but whether it
will work for this particular patient, with his personal problems at the moment of his life
in this environment, this location in this country and this region of the world.
Why test it in functional dyspepsia patients
Functional dyspepsia is part of a group of diseases called "Functional Disorders of the
Gastrointestinal Tract" that goes beyond the biomedical model:
- They are defined as variable combinations of symptoms, not explained by structural or
biochemical changes.
- The diagnostic criteria and parameters for better or worse are based on symptoms
reported by patients, this causes some skepticism in the face of more traditional
medical view. There are no objective criteria for assessing these disorders.
Why to use placebo
The use of placebo in this study is justified due to the facts:
- Symptoms of functional dyspepsia have a high rate of improvement with placebo.
Comparative studies with some drugs show that the placebo effect is up to the order of
30 to 40%.
- can not rule out the placebo effect, if the magnitude of this drug therapies are not
compared to placebo.
Justification of the study This study is justified for several reasons, but mainly by the
limitations of the biomedical model.
- The changes in the epidemiological profile (which has been occurring in recent decades)
are increasingly leaving very clear the role of psychological, socio-cultural and
spiritual factors, as expressed by the personality and lifestyle.
- The same biomedicine with its progress and sophistication is showing its inability to
provide satisfactory or conclusive answers to many problems, especially for the
subjective components that come into greater or lesser degree in any disease.
Biomedicine is too limited in its explanatory power. Many medical professionals realize the
psychological reactions of patients and their socioeconomic problems involved in the disease
but do not see how to incorporate this information in formulating diagnosis and treatment
decisions. The idea of ilness as a phenomenon more or less accidental, originating in the
biochemical processes of the body is very restricted, and therefore produces restricted
results too.
;
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04656730 -
Effect of STW5 (Iberogast ®) and STW5-II (Iberogast N®) on Transit and Tolerance of Intestinal Gas
|
Phase 4 | |
Completed |
NCT04464369 -
Functional Dyspepsia: Validation of the Leuven Postprandial Distress Scale (LPDS) in a Placebo-controlled Trial
|
Phase 4 | |
Completed |
NCT01671670 -
Acupuncture for Patients With Function Dyspepsia
|
Phase 2/Phase 3 | |
Completed |
NCT00987805 -
Efficacy of Banhasasim-tang on Functional Dyspepsia
|
Phase 4 | |
Completed |
NCT00761358 -
To Verify the Efficacy of Z-338 in Subjects With Functional Dyspepsia
|
Phase 3 | |
Completed |
NCT00693407 -
Study of Endogenous Inhibitory Modulation During Gastric and Somatic Stimulation
|
N/A | |
Recruiting |
NCT01240096 -
Mirtazapine Versus Placebo in Functional Dyspepsia
|
Phase 4 | |
Recruiting |
NCT04540549 -
Effects of Exercise on Functional Dyspepsia Based on Rome IV
|
N/A | |
Recruiting |
NCT03652571 -
Nortriptyline for the Treatment of Functional Dyspepsia
|
Phase 3 | |
Recruiting |
NCT06068114 -
Gastric Pathophysiology in Diabetes
|
||
Recruiting |
NCT03825692 -
International Clinical Study of Zhizhu Kuanzhong Capsule
|
Phase 4 | |
Not yet recruiting |
NCT04548011 -
Acupuncture of Different Treatment Frequency on Improving Quality of Life in Patients With Functional Dyspepsia
|
N/A | |
Terminated |
NCT02567578 -
A Trial to Evaluate the Efficacy and Safety of YH12852 in Patients With Functional Dyspepsia
|
Phase 2 | |
Completed |
NCT03007433 -
Assessment of GI Function to a Large Test Meal by Non-invasive Imaging
|
N/A | |
Active, not recruiting |
NCT00990405 -
Clinical Study to Evaluate the Efficacy and the Safety of Eradication Therapy for Helicobacter Pylori in Functional Dyspepsia
|
Phase 4 | |
Completed |
NCT00404534 -
Helicobacter Eradication Relief of Dyspeptic Symptoms
|
Phase 3 | |
Completed |
NCT03043625 -
Visceral Manipulation Treatment to Patients With Non-specific Neck Pain With Functional Dyspepsia
|
N/A | |
Completed |
NCT03225248 -
Efficacy and Safety of UI05MSP015CT in Functional Dyspepsia
|
Phase 3 | |
Recruiting |
NCT05587127 -
Exposure-Based CBT for Avoidant/Restrictive Food Intake in Functional Dyspepsia
|
N/A | |
Recruiting |
NCT01021475 -
Does Visceral Manipulation Works in Treating Functional Dyspepsia?
|
Phase 1 |